跳至主要内容
临床试验/IRCT20181210041918N1
IRCT20181210041918N1招募中3 期

The Effects of Probiotic Supplementation on disease progression and serum levels of inflammatory biomarkers in Patients With Multiple Sclerosis

Ahvaz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Diagnosis based on Mc Donald and MRI criteria
  • EDSS score is less than 3
  • Clinical status of relapse-remittance

排除标准

  • Unwillingness to continue cooperation
  • Exacerbation of the disease during the study
  • There is a relapse during the intervention
  • History of antibiotic use during 1 month ago
  • Consumption of any probiotic and prebiotic supplement and antibiotic in the last 1 month
  • Consumption supplements containing of vitamin, fiber, omega-3, anti-oxidants during 3 weeks before and during the study.
  • Taking non-steroidal anti-inflammatory drugs (NSAIDs), estrogen, progesterone, immunosuppressions, diuretics and corticosteroids drugs.
  • History of gastroenteritis during the last month
  • History of intestinal surgery during the past month
  • Inflammatory bowel disease (IBD), rheumatoid arthritis, systemic lupus, type 1 diabetes and other autoimmune diseases and pregnancy

研究者

相似试验